Literature DB >> 3314727

Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia.

A Mehta1, R Wootton, K N Cheng, P Penfold, D Halliday, T E Stacey.   

Abstract

The relation between hepatic glucose production rate (HGPR) and plasma concentrations of insulin and glucagon was investigated in four term neonates who had severe hypoglycaemia. The hepatic glucose production rate was less than 20% of normal for fasting term neonates in all four babies and yet insulin concentrations were never greater than 12 microU/ml; two babies had very low glucagon concentrations (less than 60 ng/l). Two further neonates with similar histories also had plasma glucagon concentrations that were also extremely low (less than 20 ng/l). A single intravenous bolus of glucagon caused a rapid rise in hepatic glucose production rate towards the normal range, which was sustained for many hours after the bolus had been given. Diazoxide given to one baby suppressed previously 'normal' insulin concentrations still further (4.2 to less than 1.6 microU/ml) and thereby restored the hepatic glucose production rate to normal. In view of the normal plasma insulin concentrations at a time when the hepatic glucose production rate was reduced, we feel that the absolute concentration of insulin may be less important than the insulin/glucagon molar ratio in the control of glucose homeostasis in this group of infants. The changing of this ratio by means of boluses of glucagon may be useful in preventing rebound hypoglycaemia, which so often occurs when dextrose infusions are reduced either accidentally or in an attempt to restart oral feeds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314727      PMCID: PMC1778564          DOI: 10.1136/adc.62.9.924

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

2.  Glucagon deficiency causing severe neonatal hypoglycemia in a patient with normal insulin secretion.

Authors:  J Vidnes; S Oyasaeter
Journal:  Pediatr Res       Date:  1977-09       Impact factor: 3.756

3.  Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia.

Authors:  C A Stanley; L Baker
Journal:  Pediatrics       Date:  1976-05       Impact factor: 7.124

4.  Control of rat liver phosphorylase, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activities by insulin and glucagon during the perinatal period.

Authors:  J R Girard; D Caquet; D Bal; I Guillet
Journal:  Enzyme       Date:  1973

5.  Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.

Authors:  M S Cohen; R H Bower; S M Fidler; R E Johnsonbaugh; J Sode
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

6.  Increased gluconeogenic substrates in the small-for-gestational-age infant.

Authors:  M W Haymond; I E Karl; A S Pagliara
Journal:  N Engl J Med       Date:  1974-08-15       Impact factor: 91.245

7.  Attenuated glucose production rate in newborn infants of insulin-dependent diabetic mothers.

Authors:  S C Kalhan; S M Savin; P A Adam
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

8.  Effect of diphenylhydantoin on insulin secretion in man.

Authors:  C Malherbe; K C Burrill; S R Levin; J H Karam; P H Forsham
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

9.  Plasma glucose, non-esterified fatty acid, insulin and growth hormone response to glucagon in the newborn.

Authors:  R D Milner; A D Wright
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

10.  Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose.

Authors:  D M Bier; R D Leake; M W Haymond; K J Arnold; L D Gruenke; M A Sperling; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

View more
  11 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?

Authors:  L Jackson; A Burchell; A McGeechan; R Hume
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

3.  Hyperinsulinaemic hypoglycaemia in small for dates babies.

Authors:  A Mehta
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 4.  Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management.

Authors:  Charles A Stanley; Paul J Rozance; Paul S Thornton; Diva D De Leon; Deborah Harris; Morey W Haymond; Khalid Hussain; Lynne L Levitsky; Mohammad H Murad; Rebecca A Simmons; Mark A Sperling; David A Weinstein; Neil H White; Joseph I Wolfsdorf
Journal:  J Pediatr       Date:  2015-03-25       Impact factor: 4.406

5.  Glucagon for hypoglycaemia in infants small for gestational age.

Authors:  P E Carter; D J Lloyd; P Duffty
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 6.  Management strategies for neonatal hypoglycemia.

Authors:  Courtney B Sweet; Stephanie Grayson; Mark Polak
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 7.  Prevention and management of neonatal hypoglycaemia.

Authors:  A Mehta
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

Review 8.  Prevention and management of neonatal hypoglycaemia.

Authors:  J M Hawdon; M P Ward Platt; A Aynsley-Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

9.  Hyperinsulinaemic hypoglycaemia in small for dates babies.

Authors:  J E Collins; J V Leonard; D Teale; V Marks; D M Williams; C R Kennedy; M A Hall
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

10.  Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon and intragastric medium chain triglyceride.

Authors:  J M Hawdon; A Aynsley-Green; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.